Althea (previously Pantheon Healthcare Group) announced it has completed the purchase of TBS Group S.p.A. (TBS), a European leading provider of clinical engineering integrated solutions.
The acquisition of TBS represents an important step in the consolidation strategy of Althea, who aims to continue the expansion process that was already started by the management for the strengthening of the presence within the existing markets and the entrance in new geographical areas.
Althea and TBS Groups share a strong presence in the Italian market, one of the most sophisticated and evolved markets in Europe, and a strong international ambition, with a complementary presence within European reference markets (UK, France, Spain) and in the US, India and Turkey. The two players have a complementary offer of integrated solutions which will allow to develop a complete range of services to add value to hospitals and diagnostic centres, more and more focused on their core business, seeking efficient and integrated solutions for managing complex medical technologies.
Althea was born in 2014 from the combination of Asteral Limited and MESA Group Holdings GmbH with the Permira funds backing and grew through further 11 acquisitions across Europe and USA. In just a few years, Althea has become one of the main providers of healthcare technology management services in Europe. It has strengthened its management team and successfully integrated the competences of the acquired companies by centralising the supply chain and by creating the only multi-country hub of excellence in the sector, dedicated to the formation and the management of high technology equipment. The Group, led by the CEO Alessandro Dogliani, now operates in 15 countries, managing more than 475,000 medical equipment across over 650 healthcare services which it supports with its pan-European logistic network.
TBS headquarters in Trieste will become a hub of excellence for research and development activities of the integrated group, not only in the existing biomedical technologies, but also for the new frontier of confluence with IT and ICT. Althea will leverage TBS’s competencies to further innovate its clinical engineering activities and ICT integrated solutions, with the goal of developing more sophisticated services for the management of big data and clinical data, also maintaining and strengthening TBS’s collaborations with primary Universities and International Research Institutes, which represent excellence in the bioengineering and innovation fields.
Alessandro Dogliani, Chief Executive Officer of Pantheon, commented: “I am glad of the success of the acquisition which demonstrates the effectiveness of the project from which it originated and unites two excellent groups in a growing and key sector for the efficient and effective management of healthcare technologies in hospitals and in European clinics. It is another important step in the right direction taken by the group and the team that I am proud to lead”.
Diego Bravar, Chairman and Founder of TBS Group, added: “The new partner will allow TBS to carry on its industrial growth and innovation development being part of an outstanding group to which TBS will contribute with its distinctive competences. I believe the new group has many development potentials, both in Italy and above all abroad and I am convinced that the combination of TBS with Pantheon will enhance this growth”.